LVIS analyzes neural information to help diagnose neurological diseases by decoding brain networks. It develops EEG software that visualizes brain activity in detail for medical professionals and institutions. The product works by processing EEG data to map and display brain networks, enabling clinicians to interpret patterns associated with neurological conditions (with beta testing through the NeuroMatch Ambassador Program for early access and feedback). LVIS differentiates itself by its focus on brain-network decoding from EEG data and by collaborating closely with healthcare providers to ensure practical reliability, rather than broad consumer tech approaches. The company's goal is to provide clinicians with precise, network-level insights from EEG to improve neurological diagnosis and patient care, delivered through software licenses and partnerships.
Company Size
11-50
Company Stage
Series B
Total Funding
$15M
Headquarters
Palo Alto, California
Founded
2015
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?